044480 — Billions Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
KR₩26bn
Enterprise Value
KR₩29bn
Revenue
KR₩42bn

Annual income statement for Billions Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	13,049	25,764	70,649	28,987	41,725
Cost of Revenue
Gross Profit	2,419	3,714	19,176	5,822	6,435
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	21,002	51,000	77,218	27,260	46,080
Operating Profit	-7,953	-25,236	-6,570	1,727	-4,355
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-26,523	-31,836	-4,390	2,397	-1,951
Provision for Income Taxes
Net Income After Taxes	-26,523	-30,692	-4,452	2,387	-1,951
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-26,667	-29,489	-18,864	-13,813	-1,964
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-26,667	-29,489	-18,864	-13,813	-1,964
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,096	-467	8.79	409	-192
Dividends per Share